The list of insurers covering Senseonics ’ diabetes device is growing. The latest? Cigna.
Germantown ’s Senseonics Holdings Inc. has just added global insurance giant Cigna Corp. to the roster of payers covering its blood-sugar sensor system for diabetes patients.
Cigna’s coverage of the local medical device company’s implantable continuous glucose monitoring (CGM) system called Eversense — which detects glucose levels to inform whether insulin, food or exercise is needed — became effective Feb. 15, Senseonics (NYSE: SENS) announced Tuesday. The Connecticut insurer is one of…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Sara Gilgore Source Type: news
More News: Biotechnology | Diabetes | Endocrinology | Health Management | Insulin | Insurance | Insurers | Medical Devices | Sports Medicine | Sugar